Skip to main content

PSCA Antibody (C1)

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-41639

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-41639

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 kappa Clone # C1

Concentration

1 mg/ml

Product Specifications

Immunogen

Immunized with recombinant Human PSCA (Uniprot#: O43653; Leu13-Ser86 (Uniprot#: O43653)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1 kappa

Scientific Data Images for PSCA Antibody (C1)

PSCA Antibody (C1)

Western Blot: PSCA Antibody (C1) [NBP3-41639] -

Western Blot: PSCA Antibody (C1) [NBP3-41639] - Sample: Recombinant PSCA, Human.

Applications for PSCA Antibody (C1)

Application
Recommended Usage

Western Blot

0.01-2ug/mL

Formulation, Preparation, and Storage

Purification

Protein A or G purified

Formulation

0.01M PBS, pH7.4, 50% glycerol

Preservative

0.05% Proclin 300

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: PSCA

The PSCA gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large pro

Long Name

Prostate Stem Cell Antigen

Alternate Names

PRO232

Gene Symbol

PSCA

Additional PSCA Products

Product Documents for PSCA Antibody (C1)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for PSCA Antibody (C1)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...